![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
ANTICANCER ACTIVITY AND MOLECULAR DOCKING OF SOME SYNTHESIZED 2-THIOHYDANTOIN DERIVATIVES
Mohamed Abd El-Moneim, Elsherbiny H. Elsayed and Maha El-Ashry*
ABSTRACT Objective: the present work is designed for synthesis of a series of novel 2- thiohydantoin derivatives, description of the electron impact (EI) ionization mass spectral fragmentation patterns and evaluation of them against human breast cancer cells (MCF-7) and human prostate cancer cells (PC-3). Methods: A series of novel 3-[(2,5-dihydroxybenzylidene)amino]-2-thiohydantoin derivatives have been synthesized. The structures of the synthesized compounds were characterized by spectroscopic methods such as IR, HNMR, 13CNMR, mass spectroscopy and elemental analysis. The anti-tumor activity of the new compounds were evaluated against human breast cancer cells (MCF-7) and human prostate cancer cells (PC-3). Molecular docking also evaluated. Results: The spectroscopic data clearly confirmed the structure of the newly synthesized compounds. The anticancer activity and molecular docking for the compounds were evaluated. Among the tested compounds 3 and 7 exhibited the highest activity. Conclusion: 2-thiohydantoin derivatives containing (2,3-dihydroxybenzylidene)amino substituent were synthesized. The synthesized compounds exhibited moderate anticancer activities. On docking study, the most favorable interaction between the synthesized compounds and the protein receptor (3hb5) were with compounds 6 and 2. Keywords: 2-Thiohydantoin, Synthesis, Antitumor, Molecular Docking. [Download Article] [Download Certifiate] |